findmyKOL
Clinical trialNCT04562051UnknownObservational

Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients

SponsorWest China HospitalEnrollment100HBVKidney Transplantation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multicenter, prospective, observational study to compare the efficacy and safety of stratified prophylaxis based on donors' and recipients' risk factors vs routine prophylaxis bases on clinical experience in living kidney transplantation from HBsAg+ donors to HBsAg- recipients. The follow-up period was 2 years after renal transplantation. The primary outcome was prevention failure of HBV transmission (any one of HBsAg - → +, HBV DNA - → +, HBeAg - → +, HBeAb - → +, HBcAb - → +, active liver function damage and death in the recipient).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Honglan Zhou, MD

    The First Hospital of Jilin University

    Principal Investigator
    clinicaltrials.gov ↗
  • Hongtao Liu, MD

    The First Affiliated Hospital of USTC, University of Science and Technology of China

    Principal Investigator
    clinicaltrials.gov ↗
  • Saifu Yin, MB

    Organ Transplant Center, Department of Urology, West China Hospital

    Principal Investigator
    clinicaltrials.gov ↗
  • Turun Song, MD

    Organ Transplant Center, Department of Urology, West China Hospital

    Principal Investigator
    clinicaltrials.gov ↗
  • Wenjun Shang, MD

    The First Affiliated Hospital of Zhengzhou University

    Principal Investigator
    clinicaltrials.gov ↗
  • Xianding Wang, MD

    Organ transplant center, Department of Urology, West China Hospital

    Study Director
    clinicaltrials.gov ↗
  • Yu Fan, MD

    Organ Transplant Center, Department of Urology, West China Hospital

    Principal Investigator
    clinicaltrials.gov ↗
  • Zhongli Huang, MD

    Organ Transplant Center, Department of Urology, West China Hospital

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Tao Lin

    Chengdu, Sichuan, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Sept 2020
Primary completion
1 Dec 2025
Completion
1 Jun 2026
Last update posted
29 Nov 2023
Registered enrollment
100
Registry id
NCT04562051
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.